Prolacta honors and values breastfeeding mothers and their committment to the health of babies
Clinically proven to improve health outcomes of critically ill preemies
Committed to scientific and clinical research in breast milk
Prolact Product Safety

Hospital Cost Savings through use of Prolacta Human Milk Products

Did you know that the only way to provide an exclusively human milk-based, fortified diet for extremely premature infants* in your neonatal intensive care unit (NICU) is by fortifying human milk with Prolact+ H2MF®. And did you know that implementing an all human milk-based diet in your facility can actually save your hospital money?

A study published in the journal, Breastfeeding Medicine found that a 100% human milk-based diet, which included Prolact+ H2MF®, may result in a net savings of medical care resources by reducing the incidence of necrotizing enterocolitis (NEC) among extremely preterm infants, when compared with feeding these infants HMF produced from cow milk or cow milk-based preemie formula. The study showed the adjusted incremental costs of medical NEC and surgical NEC** over and above the average costs incurred for infants weighing 500-1250g at birth without NEC in 2011 were $74,004 and $198,040 per infant, respectively. Extremely premature infants fed an exclusively human milk diet including the only human milk-based HMF, Prolact+ H2MF® human milk fortifier, had lower expected costs of hospitalization, resulting in net direct savings of $8,167.17 per infant. The study also found that extremely premature infants who were not diagnosed with necrotizing enterocolitis spent approximately 3.9 fewer days in the NICU than infants who were diagnosed.

For the typical NICU, this means that in addition to the health benefits of using exclusively human milk-based nutrition for extremely preterm infants, there may also be a significant cost savings.


* Extremely premature infants, as defined in the study, are those born weighing between 500 and 1250 grams.
** Necrotizing Enterocolitis is a dangerous and severe complication that often affects extremely preterm infants, in which the intestinal tissue disintegrates. NEC requires surgical intervention to remove the dead portions of the intestines in 20% – 40% of the cases. The fatality rate of NEC surgery is as high as 50%.1

  1. Ganapathy V, Hay JW, Kim JH. “Costs of Necrotizing Enterocolitis and Cost-Effectiveness of Exclusively Human Milk-Based Products in Feeding Extremely Premature Infants”. Breastfeeding Medicine. 2011. DOI: 10.1089 / bfm.2011.0002

Speak to a Reimbursement Specialist

Pharmacoeconomics Publication

Access the study from the Journal of Perinatology Read More About Hospital Cost Savings Associated with Feeding Prolact+ HMF in Extremely Premature Infants

Follow Us!